PhRMA
OCTOBER 26, 2022
A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.
Drug Topics
OCTOBER 26, 2022
The Flip the Pharmacy program provides tools to pharmacy technicians and non-pharmacy support staff Mitchell’s Drug Stores to help provide patient care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
OCTOBER 26, 2022
Research suggests that positron emission tomography scans are effective at detecting early and late Hodgkin’s lymphoma, and the results could help manage and reduce toxicity from current chemotherapies.
STAT
OCTOBER 26, 2022
Who gets better medical care in the United States: “addicts,” or “people with substance use disorders”? The terms, of course, mean functionally the same thing. But in the field of addiction medicine, the question presents something of a crisis. Even as drugs and alcohol claim 200,000 lives each year, many who seek addiction treatment are greeted by the harsh, stigmatizing labels that many Americans don’t think twice about: Words like addict, alcoholic, junkie,
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 26, 2022
Food insecurity has previously been linked to adverse cardiovascular outcomes, but research is limited regarding the local food environment and the association with death from heart failure.
pharmaphorum
OCTOBER 26, 2022
Drugmakers Pfizer and Flynn Pharma have formally launched an appeal against a £70 million ($84 million) fine levied by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. The two drugmakers were fined in July, after the CMA upheld a preliminary judgment that Pfizer and Flynn had abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to swell from around £2 million a year in 2012 to £50 million the following y
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
OCTOBER 26, 2022
The VP of regulatory affairs and global patient safety explains why her line of work lets her do “a little of everything,” and the company’s plans to score a new approval for its blockbuster drug.
Pharmacy Times
OCTOBER 26, 2022
Understanding the novel mechanisms of multiple myeloma can help to develop better next-generation therapies that overcome drug resistance.
STAT
OCTOBER 26, 2022
The 340B Drug Discount Program turns 30 on Nov. 4. This once-obscure drug access program began modestly, but has grown to be the second-largest federal prescription drug program , behind Medicare Part D. It’s time, past time, really, for an honest conversation about it. In a nutshell, the 340B program allows certain federally funded health clinics (grantees) and nonprofit hospitals (covered entities) to buy drugs for their outpatients at prices typically only available to state Medicaid p
Pharmacy Times
OCTOBER 26, 2022
Highest prevalence is seen among adults, outpatients, and women and can cause persistent severe anosmia or hyposmia, findings indicate.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
OCTOBER 26, 2022
Psoriasis is a tricky disease to manage, as drawbacks and side effects loom with each and every type of treatment. Anyone who watches television has heard the list of potential adverse reactions, considering that commercials for psoriasis treatments are seemingly only outnumbered by goofy ads for auto insurance. Topicals — creams, ointments, foams, and lotions applied directly to the affected areas of the skin — don’t get nearly as much TV time as their systemic biologic counterparts, the
Drug Store News
OCTOBER 26, 2022
With the impending “tripledemic” of respiratory illness, flu and COVID-19, NACDS is imploring the administration to plan now, extend the PREP Act and enact long-term solutions to ensure access to these services.
pharmaphorum
OCTOBER 26, 2022
Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other interstitial lung diseases (ILDs). The drug was highlighted at Boehringer’s R&D update earlier this year as one of the most promising candidates among 15 new medicines it plans to bring to market by 2025, fuelled by a €25 billion R&D spend.
STAT
OCTOBER 26, 2022
Terry Wilcox’s grandmother lived in an isolated house at the top of a hill overlooking the magical mountains and valleys of the Ozarks until, as she tells it, “the day we literally had to drag her off of it.” Wilcox, like many others in her generation, has been in the tricky position of having to take care of aging parents and in-laws in addition to her young twins.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Digital Pharmacist
OCTOBER 26, 2022
On October 7 th , 2022 the U.S. Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.
pharmaphorum
OCTOBER 26, 2022
When people think about pharma, they often think about “big” pharma: large, faceless corporations. But Giacomo Chiesi, head of Chiesi Global Rare Diseases, thinks of his 6,000-person company as a family business. And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community.
Pharmacy Times
OCTOBER 26, 2022
Answering questions, monitoring, medication therapy, lifestyle modifications help prevent type 2 diabetes.
STAT
OCTOBER 26, 2022
Apply for STAT Madness! Submit your application to be considered for the 2023 STAT Madness, a bracket-style tournament to find the best innovations in science and medicine. Nominations close January 17th, 2023. The bracket goes live March 1st, 2023!
Pharmacy Times
OCTOBER 26, 2022
Study results indicate durable immune response from bivalent booster after 3 months of follow-up.
STAT
OCTOBER 26, 2022
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET. Data sharing is essential to developing everything from medicines to artificial intelligence-based tools, but often ulterior commercial motives corrupt it.
PharmaVoice
OCTOBER 26, 2022
The Stanford researcher and biotech entrepreneur discusses how click and bioorthogonal chemistry could revolutionize drug development.
STAT
OCTOBER 26, 2022
D.A. Wallach’s first meeting with his business partner could have been the setting of a romantic comedy. Wallach met Tim Wright in 2018 at a beachside restaurant in Del Mar, Calif., where they dissected the health care industry over seafood. “Then we ended up, if I remember correctly, walking on the beach. It was very romantic,” Wallach said.
Drug Store News
OCTOBER 26, 2022
Several attorney generals sent a letter to the CEOs of Albertsons and Kroger demanding that Albertsons delay a $4 billion payout to stockholders.
Drug Topics
OCTOBER 26, 2022
More and more women are being diagnosed with ADHD in adulthood. What's behind this increase?
Drug Store News
OCTOBER 26, 2022
The new facility, in Jeffersonville, Ohio will distribute pharmaceutical, over-the-counter and home healthcare products.???????
European Pharmaceutical Review
OCTOBER 26, 2022
Some 70-80% of antibody drug conjugate (ADC) developers outsource their operations to contract development and manufacturing organisations (CDMOs) to yield cost savings opportunities, according to a recent market report. Manufacturing agreements emerged as the most popular type of partnership model for ADC developers, adopted by 18 percent of stakeholders, followed by product development agreements (16 percent) and research agreements (15 percent), the market research found. .
Outsourcing Pharma
OCTOBER 26, 2022
A âsignificant shiftâ is under way in global outsourcing strategies: with the sector moving away from phase-appropriate development in favor of a more forward-looking model â with experts advising starting the search for an outsourcing partner as early as possible.
European Pharmaceutical Review
OCTOBER 26, 2022
Gallogly College of Engineering at The University of Oklahoma (OU) has announced it will open the OU Bioprocessing Core Facility, a shared research centre for biopharmaceutical manufacturing and bioprocess engineering in 2023. Organisations who will benefit from the shared site include academia, clinical research organisations and start-ups. A total of $7 million will support those involved to equip the facility with state-of-the-art technology.
Outsourcing Pharma
OCTOBER 26, 2022
The ABPI releases a report that shows the number of clinical trials taking place in the UK fell by a large amount between the years 2017 and 2021.
Drug Store News
OCTOBER 26, 2022
To celebrate its partnership with Ulta Beauty, Bubble Skincare is launching its new Over Night Hydrating Mask at the retailer.
European Pharmaceutical Review
OCTOBER 26, 2022
Included in this Guide to: The changing face of outsourcing. With pharma/biopharma companies looking to select CDMO partners earlier than before, and in a competitive market, what approaches can be adopted? Here, EPR explores some recent trends and evolving strategies. Make confident operational decisions by understanding your microflora. Are you leveraging all the information from your QC data?
Pharmacy Times
OCTOBER 26, 2022
ASCP 2022 session presenters discuss medications that can cause QTc prolongation, with a particular emphasis on a review of the literature with regards to QTc prolongation and antipsychotics.
European Pharmaceutical Review
OCTOBER 26, 2022
Gedeon Richter UK Ltd has announced that the UK National Institute for Health and Care Excellence (NICE) has recommended the first oral gonadotropin-releasing hormone (GnRH) receptor antagonist for adults of reproductive age with moderate-to-severe symptoms of uterine fibroids on the National Health Service (NHS) in England and Wales. Ryeqo, the once-a-day relugolix combination therapy comprises of 40mg of relugolix, 1mg estradiol and 0.5mg norethisterone acetate.
Pharmacy Times
OCTOBER 26, 2022
The objective of the trial was to compare letermovir with valganciclovir in preventing CMV disease in adults who received a kidney transplant and who are at high risk for CMV disease.
Expert insights. Personalized for you.
265 
Let's personalize your content